Tumor Mutational Load: A Novel Predictor for Clinical Benefit of Pembrolizumab

Fang-Chi Hsu1, Yun Yen2,3

  • 1Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.

Related Concept Videos